We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy

By LabMedica International staff writers
Posted on 25 Apr 2025

Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or Tumor-Node-Metastasis (TNM) cancer staging system, which helps determine the stage of cancer, and (2) the American Thyroid Association (ATA) risk classification system, which is used to categorize cancer risk. More...

These systems are vital for predicting patient survival and guiding treatment decisions. However, manually integrating the complex clinical data into these systems can be time-consuming and inefficient. Now, researchers have introduced the world’s first artificial intelligence (AI) model capable of classifying both the stage and risk category of thyroid cancer with remarkable accuracy, exceeding 90%. This innovative AI model, featured in the journal npj Digital Medicine, is set to significantly reduce pre-consultation preparation time for frontline clinicians by approximately 50%.

An interdisciplinary research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed, Hong Kong) developed an AI assistant that employs large language models (LLMs) such as ChatGPT and DeepSeek. These models are designed to understand and process human language, helping to analyze clinical documents and improve the accuracy and efficiency of thyroid cancer staging and risk classification. The model utilizes four offline, open-source LLMs—Mistral (Mistral AI), Llama (Meta), Gemma (Google), and Qwen (Alibaba)—to interpret free-text clinical documents. The AI model was trained using an open-access data set from the United States that included pathology reports from 50 thyroid cancer patients from The Cancer Genome Atlas Program (TCGA), with validation done using pathology reports from 289 TCGA patients and 35 pseudo cases created by endocrine surgeons.

By combining the outputs from all four LLMs, the research team was able to enhance the overall performance of the AI model, achieving an accuracy rate ranging from 88.5% to 100% in ATA risk classification and 92.9% to 98.1% in AJCC cancer staging. In addition to its high accuracy in extracting and analyzing complex information from pathology reports, operation records, and clinical notes, the AI model also drastically reduces doctors’ preparation time by nearly half compared to manual interpretation. A significant advantage of this model is its ability to operate offline, allowing it to be deployed locally without the need to share or upload sensitive patient data, thereby ensuring maximum patient privacy. The AI model’s versatility means it can be easily integrated into a variety of healthcare settings, both public and private, as well as in international healthcare and research institutions.

“In line with government’s strong advocacy of AI adoption in healthcare, as exemplified by the recent launch of LLM-based medical report writing system in the Hospital Authority, our next step is to evaluate the performance of this AI assistant with a large amount of real-world patient data,” said Dr. Carlos Wong, Honorary Associate Professor in the Department of Family Medicine and Primary Care, School of Clinical Medicine, HKUMed. “Once validated, the AI model can be readily deployed in real clinical settings and hospitals to help clinicians improve operational and treatment efficiency.”

Related Links:
HKUMed


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Blood Gas and Chemistry Analysis System
Edan i500
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.